Spectrums of Amyotrophic Lateral Sclerosis. Группа авторов

E.M. et al. (2015). C9orf72 promoter hypermethylation is neuroprotective neuroimaging and neuropathologic evidence. Neurology 84 (16): 1622–1630.

      96 96. Xi, Z., Zhang, M., Bruni, A.C. et al. (2015). The C9orf72 repeat expansion itself is methylated in ALS and FTLD patients. Acta Neuropathol 129 (5): 715–727.

      97 97. Bauer, P.O. (2016). Methylation of C9orf72 expansion reduces RNA foci formation and dipeptide‐repeat proteins expression in cells. Neurosci Lett 612: 204–209.

      98 98. Zhang, M., Tartaglia, M.C., Moreno, D. et al. (2017). DNA methylation age‐acceleration is associated with disease duration and age at onset in C9orf72 patients. Acta Neuropathol 134 (2): 271–279.

      99 99. Pal, S. and Tyler, J.K. (2016). Epigenetics and aging. Sci Adv 2 (7): e1600584.

      100 100. Williams, A.H., Valdez, G., Moresi, V. et al. (2009). Micro RNA‐206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326 (5959): 1549–1554.

      101 101. Bruneteau, G., Simonet, T., Bauche, S. et al. (2013). Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression. Brain 136 (Pt 8): 2359–2368.

      102 102. Lapucci, A., Cavone, L., Buonvicino, D. et al. (2017). Effect of class II HDAC inhibition on glutamate transporter expression and survival in SOD1‐ALS mice. Neurosci Lett 656: 120–125.

      103 103. Pigna, E., Simonazzi, E., Sanna, K. et al. (2019). Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine 40: 717–732.

      104 104. Boutillier, A.L., Tzeplaeff, L., and Dupuis, L. (2019). The dark side of HDAC inhibition in ALS. EBioMedicine 41: 38–39.